Acquiring Company
Novonesis
Acquired Company
MicroBioGen
Copenhagen
AustraliaManufacturingAgriculture and FarmingBiotechnologyDescription
Novonesis has signed an agreement to acquire the remaining share of MicroBioGen to enhance its yeast capabilities. This acquisition follows a previous 23% stake and a decade-long partnership in yeast solutions for bioethanol. The transaction awaits customary regulatory approvals before completion. MicroBioGen is recognized for its elite yeast genetics and industrial collaboration.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired MicroBioGen?
MicroBioGen was acquired by Novonesis, based in Copenhagen. The deal was reported on August 10, 2026. Novonesis is a global leader in biosolutions, specializing in fermentation technology. The company focuses on innovative production methods to meet growing customer demands. Novonesis is privately held and operates in Manufacturing.
When did Novonesis acquire MicroBioGen?
Novonesis's acquisition of MicroBioGen was reported on August 10, 2026. Novonesis has signed an agreement to acquire the remaining share of MicroBioGen to enhance its yeast capabilities. This acquisition follows a previous 23% stake and a decade-long partnership in yeast solutions for bioethanol. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does MicroBioGen do?
MicroBioGen is an Australian biotechnology company that specializes in yeast strain improvements for industrial applications. They have developed elite yeast genetics over 20 years and provide ‘Yeast Innovation as a Service’ to global industry leaders. It is privately held, operating in Biotechnology, and is based in Australia.